Sprint Bioscience AB (SPRINT) — Cash Flow Quality Index
Sprint Bioscience AB (SPRINT) has a Cash Flow Quality Index of 1.02x as of December 2025. Operating cash flow of Skr115.84 Million exceeds net income of Skr113.17 Million, indicating high earnings quality where cash backs reported profits. Explore SPRINT operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sprint Bioscience AB Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Sprint Bioscience AB across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check SPRINT cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Sprint Bioscience AB (2016–2025)
Year-by-year earnings quality comparison for Sprint Bioscience AB. For live market cap and the full company financial profile, see market value of Sprint Bioscience AB.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.91x | Skr83.53 Million | Skr91.74 Million | ▼ -47.6% |
| 2016 | 1.74x | Skr7.93 Million | Skr4.57 Million | — |